Skip to content

Study · In vitro (cells) · rat · 2018

8 results

Effects of Kisspeptin-10 on Hypothalamic Neuropeptides and Neurotransmitters Involved in Appetite Control.

Orlando G, Leone S, Ferrante C, Chiavaroli A, Mollica A, Stefanucci A, Macedonio G, Dimmito MP, Leporini L, Menghini L, Brunetti L, Recinella L

Molecules (Basel, Switzerland)24 Nov 2018Cited by 35 (Europe PMC)

Summary

Besides its role as key regulator in gonadotropin releasing hormone secretion, reproductive function, and puberty onset, kisspeptin has been proposed to act as a bridge between energy homeostasis and reproduction. In the present study, to characterize the role of hypothalamic kisspeptin as metabolic regulator, we evaluated the effects of kisspeptin-10 on neuropeptide Y (NPY) and brain-derived neurotrophic factor (BDNF) gene expression and the extracellular dopamine (DA), norepinephrine (NE), serotonin (5-hydroxytriptamine, 5-HT), dihydroxyphenylacetic acid (DOPAC), and 5-hydroxyindoleacetic acid (5-HIIA) concentrations in rat hypothalamic (Hypo-E22) cells. Our study showed that kisspeptin-10 in the concentration range 1 nM⁻10 μM was well tolerated by the Hypo-E22 cell line. Moreover, kisspeptin-10 (100 nM⁻10 μM) concentration independently increased the gene expression of NPY while BDNF was inhibited only at the concentration of 10 μM. Finally, kisspeptin-10 decreased 5-HT and DA, leaving unaffected NE levels. The inhibitory effect on DA and 5-HT is consistent with the increased peptide-induced DOPAC/DA and 5-HIIA/5-HT ratios. In conclusion, our current findings suggesting the increased NPY together with decreased BDNF and 5-HT activity following kisspeptin-10 would be consistent with a possible orexigenic effect induced by the peptide.
CC BYText from Europe PMC. Highlighted sentences are the source of results.

Results from this study8

8 results from studies that gave the peptide. No result from this study comes from people.

  1. 01LabIn vitro (cells)Safety outcome

    In rat hypothalamic Hypo-E22 cells, kisspeptin‑10 from 1 nM to 10 µM was well tolerated.

    In plain wordsIn lab-grown rat brain cells, kisspeptin‑10 was well tolerated across the tested concentrations.

    Outcome
    No significant changeCell tolerability
    Study

    ratn: not reported in source

    Hypo-E22 rat hypothalamic cell line
    Outcome group
    Adverse events · Metabolic and weight
    Studied dose
    1 nM to 10 µMAs given in this study (rat).

    Source sentences

    Summary
    Our study showed that kisspeptin-10 in the concentration range 1 nM⁻10 μM was well tolerated by the Hypo-E22 cell line.
    1 context sentence
    Summary · context
    we evaluated the effects of kisspeptin-10 on neuropeptide Y (NPY) and brain-derived neurotrophic factor (BDNF) gene expression and the extracellular dopamine (DA), norepinephrine (NE), serotonin (5-hydroxytriptamine, 5-HT), dihydroxyphenylacetic acid (DOPAC), and 5-hydroxyindoleacetic acid (5-HIIA) concentrations in rat hypothalamic (Hypo-E22) cells.
  2. 02LabIn vitro (cells)Mechanism

    In rat hypothalamic Hypo-E22 cells, kisspeptin‑10 increased neuropeptide Y gene expression at 100 nM to 10 µM, independent of concentration.

    In plain wordsIn lab-grown rat brain cells, kisspeptin‑10 raised the gene activity of neuropeptide Y, an appetite signal.

    Outcome
    IncreaseNPY gene expression
    Study

    ratn: not reported in source

    Hypo-E22 rat hypothalamic cell line
    Outcome group
    Appetite and food intake · Metabolic and weight
    Studied dose
    100 nM to 10 µMAs given in this study (rat).

    Source sentences

    Summary
    Moreover, kisspeptin-10 (100 nM⁻10 μM) concentration independently increased the gene expression of NPY while BDNF was inhibited only at the concentration of 10 μM.
    1 context sentence
    Summary · context
    we evaluated the effects of kisspeptin-10 on neuropeptide Y (NPY) and brain-derived neurotrophic factor (BDNF) gene expression and the extracellular dopamine (DA), norepinephrine (NE), serotonin (5-hydroxytriptamine, 5-HT), dihydroxyphenylacetic acid (DOPAC), and 5-hydroxyindoleacetic acid (5-HIIA) concentrations in rat hypothalamic (Hypo-E22) cells.
  3. 03LabIn vitro (cells)Mechanism

    In rat hypothalamic Hypo-E22 cells, kisspeptin‑10 inhibited BDNF gene expression only at 10 µM.

    In plain wordsIn lab-grown rat brain cells, kisspeptin‑10 lowered BDNF gene activity, but only at the highest concentration.

    Outcome
    DecreaseBDNF gene expression
    Study

    ratn: not reported in source

    Hypo-E22 rat hypothalamic cell line
    Outcome group
    Appetite and food intake · Metabolic and weight
    Studied dose
    10 µMAs given in this study (rat).

    Source sentences

    Summary
    Moreover, kisspeptin-10 (100 nM⁻10 μM) concentration independently increased the gene expression of NPY while BDNF was inhibited only at the concentration of 10 μM.
    1 context sentence
    Summary · context
    we evaluated the effects of kisspeptin-10 on neuropeptide Y (NPY) and brain-derived neurotrophic factor (BDNF) gene expression and the extracellular dopamine (DA), norepinephrine (NE), serotonin (5-hydroxytriptamine, 5-HT), dihydroxyphenylacetic acid (DOPAC), and 5-hydroxyindoleacetic acid (5-HIIA) concentrations in rat hypothalamic (Hypo-E22) cells.
  4. 04LabIn vitro (cells)Mechanism

    In rat hypothalamic Hypo-E22 cells, kisspeptin‑10 decreased extracellular serotonin.

    In plain wordsIn lab-grown rat brain cells, kisspeptin‑10 lowered serotonin levels.

    Outcome
    DecreaseExtracellular serotonin (5-HT)
    Study

    ratn: not reported in source

    Hypo-E22 rat hypothalamic cell line
    Outcome group
    Appetite and food intake · Metabolic and weight
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Finally, kisspeptin-10 decreased 5-HT and DA, leaving unaffected NE levels.
    1 context sentence
    Summary · context
    we evaluated the effects of kisspeptin-10 on neuropeptide Y (NPY) and brain-derived neurotrophic factor (BDNF) gene expression and the extracellular dopamine (DA), norepinephrine (NE), serotonin (5-hydroxytriptamine, 5-HT), dihydroxyphenylacetic acid (DOPAC), and 5-hydroxyindoleacetic acid (5-HIIA) concentrations in rat hypothalamic (Hypo-E22) cells.
  5. 05LabIn vitro (cells)Mechanism

    In rat hypothalamic Hypo-E22 cells, kisspeptin‑10 decreased extracellular dopamine.

    In plain wordsIn lab-grown rat brain cells, kisspeptin‑10 lowered dopamine levels.

    Outcome
    DecreaseExtracellular dopamine (DA)
    Study

    ratn: not reported in source

    Hypo-E22 rat hypothalamic cell line
    Outcome group
    Appetite and food intake · Metabolic and weight
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Finally, kisspeptin-10 decreased 5-HT and DA, leaving unaffected NE levels.
    1 context sentence
    Summary · context
    we evaluated the effects of kisspeptin-10 on neuropeptide Y (NPY) and brain-derived neurotrophic factor (BDNF) gene expression and the extracellular dopamine (DA), norepinephrine (NE), serotonin (5-hydroxytriptamine, 5-HT), dihydroxyphenylacetic acid (DOPAC), and 5-hydroxyindoleacetic acid (5-HIIA) concentrations in rat hypothalamic (Hypo-E22) cells.
  6. 06LabIn vitro (cells)Mechanism

    In rat hypothalamic Hypo-E22 cells, kisspeptin‑10 left extracellular norepinephrine unaffected.

    In plain wordsIn lab-grown rat brain cells, kisspeptin‑10 did not change norepinephrine levels.

    Outcome
    No significant changeExtracellular norepinephrine (NE)
    Study

    ratn: not reported in source

    Hypo-E22 rat hypothalamic cell line
    Outcome group
    Appetite and food intake · Metabolic and weight
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Finally, kisspeptin-10 decreased 5-HT and DA, leaving unaffected NE levels.
    1 context sentence
    Summary · context
    we evaluated the effects of kisspeptin-10 on neuropeptide Y (NPY) and brain-derived neurotrophic factor (BDNF) gene expression and the extracellular dopamine (DA), norepinephrine (NE), serotonin (5-hydroxytriptamine, 5-HT), dihydroxyphenylacetic acid (DOPAC), and 5-hydroxyindoleacetic acid (5-HIIA) concentrations in rat hypothalamic (Hypo-E22) cells.
  7. 07LabIn vitro (cells)Mechanism

    In rat hypothalamic Hypo-E22 cells, kisspeptin‑10 increased the DOPAC/DA ratio.

    In plain wordsIn lab-grown rat brain cells, kisspeptin‑10 raised the ratio of a dopamine breakdown product to dopamine.

    Outcome
    IncreaseDOPAC/DA ratio
    Study

    ratn: not reported in source

    Hypo-E22 rat hypothalamic cell line
    Outcome group
    Appetite and food intake · Metabolic and weight
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Finally, kisspeptin-10 decreased 5-HT and DA, leaving unaffected NE levels. The inhibitory effect on DA and 5-HT is consistent with the increased peptide-induced DOPAC/DA and 5-HIIA/5-HT ratios.
    1 context sentence
    Summary · context
    we evaluated the effects of kisspeptin-10 on neuropeptide Y (NPY) and brain-derived neurotrophic factor (BDNF) gene expression and the extracellular dopamine (DA), norepinephrine (NE), serotonin (5-hydroxytriptamine, 5-HT), dihydroxyphenylacetic acid (DOPAC), and 5-hydroxyindoleacetic acid (5-HIIA) concentrations in rat hypothalamic (Hypo-E22) cells.
  8. 08LabIn vitro (cells)Mechanism

    In rat hypothalamic Hypo-E22 cells, kisspeptin‑10 increased the 5-HIAA/5-HT ratio.

    In plain wordsIn lab-grown rat brain cells, kisspeptin‑10 raised the ratio of a serotonin breakdown product to serotonin.

    Outcome
    Increase5-HIAA/5-HT ratio
    Study

    ratn: not reported in source

    Hypo-E22 rat hypothalamic cell line
    Outcome group
    Appetite and food intake · Metabolic and weight
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Finally, kisspeptin-10 decreased 5-HT and DA, leaving unaffected NE levels. The inhibitory effect on DA and 5-HT is consistent with the increased peptide-induced DOPAC/DA and 5-HIIA/5-HT ratios.
    1 context sentence
    Summary · context
    we evaluated the effects of kisspeptin-10 on neuropeptide Y (NPY) and brain-derived neurotrophic factor (BDNF) gene expression and the extracellular dopamine (DA), norepinephrine (NE), serotonin (5-hydroxytriptamine, 5-HT), dihydroxyphenylacetic acid (DOPAC), and 5-hydroxyindoleacetic acid (5-HIIA) concentrations in rat hypothalamic (Hypo-E22) cells.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    10 Oct 2026, 09:43 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 03:04 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.